Latest AI and machine learning research in skin cancer for healthcare professionals.
PURPOSE: To develop a deep learning (DL) model for diagnosing ocular surface tumors and evaluating i...
BACKGROUND: Uveal melanoma (UM), the most common form of ocular melanoma, represents poor prognosis,...
Increasing evidence suggests that Graves' disease (GD) may increase the risk of thyroid cancer (THCA...
In metastatic melanoma with a BRAFV600 mutation, inhibitors of BRAF and MEK have improved survival. ...
BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality gl...
BACKGROUND: Tumor evolution is a spatiotemporal dynamic process orchestrated by the interplay of gen...
Triple-negative breast cancer (TNBC) is the most violent type of breast cancer, in which estrogen re...
RATIONALE AND OBJECTIVES: The non-invasive biomarkers for predicting progression-free survival (PFS)...
Chimeric antigen receptor (CAR)-T cell immunotherapy shows significant success in hematologic malign...
Cancer immunotherapy is increasingly moving toward personalized, precision-based strategies, with ca...
Esophageal squamous cell carcinoma (ESCC) lacks a standardized classification system, resulting in i...
The advent of immunotherapy and targeted therapy has revolutionized oncology treatment in recent yea...
Lipid nanoparticle (LNP)-mRNA technology has profoundly transformed the biomedical landscape, establ...
BACKGROUND: High naevus counts and ultraviolet photodamage are strong risk factors for melanoma. How...
Immune checkpoint blockade, particularly programmed cell death protein 1 inhibition, has redefined t...
Chimeric antigen receptor natural killer (CAR-NK) cell therapy is an emerging cancer treatment offer...
Esophageal cancer surgery is evolving from technical standardization to a paradigm of personalized, ...
BACKGROUND: The response of resectable non-small cell lung cancer (NSCLC) to neoadjuvant immunothera...
Automatic skin lesion segmentation is one of the key pivotal tasks in dermatological image processin...
Tyrosine kinase inhibitor (TKI) combined with immunotherapy regimens are now widely used for treatin...
Artificial intelligence systems are beginning to function as "co-scientists" in cancer research, gen...